Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Frequency Therapeutics stock | $8.85

Learn how to easily invest in Frequency Therapeutics stock.

Frequency Therapeutics, Inc
NASDAQ: FREQ - USD
BIOTECHNOLOGY
$8.01
-$0.01 (-0.12%)

Frequency Therapeutics, Inc is a biotechnology business based in the US. Frequency Therapeutics shares (FREQ) are listed on the NASDAQ and all prices are listed in US Dollars. Frequency Therapeutics employs 83 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Frequency Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FREQ – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Frequency Therapeutics stock price (NASDAQ: FREQ)

Use our graph to track the performance of FREQ stocks over time.

Frequency Therapeutics shares at a glance

Information last updated 2021-07-23.
Latest market close$8.85
52-week range$7.34 - $58.37
50-day moving average $9.33
200-day moving average $22.51
Wall St. target price$16.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.64

Buy Frequency Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Frequency Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Frequency Therapeutics price performance over time

Historical closes compared with the close of $8.85 from 2021-05-28

1 week (2021-07-18) N/A
1 month (2021-06-29) -11.23%
3 months (2021-04-29) -20.77%
6 months (2021-01-25) N/A
1 year (2020-07-25) N/A
2 years (2019-07-25) N/A
3 years (2018-07-25) N/A
5 years (2016-07-25) N/A

Frequency Therapeutics financials

Revenue TTM $34.4 million
Gross profit TTM $5 million
Return on assets TTM -11.51%
Return on equity TTM -24.53%
Profit margin -122.12%
Book value $5.19
Market capitalisation $269.6 million

TTM: trailing 12 months

Shorting Frequency Therapeutics shares

There are currently 5.5 million Frequency Therapeutics shares held short by investors – that's known as Frequency Therapeutics's "short interest". This figure is 8.6% down from 6.0 million last month.

There are a few different ways that this level of interest in shorting Frequency Therapeutics shares can be evaluated.

Frequency Therapeutics's "short interest ratio" (SIR)

Frequency Therapeutics's "short interest ratio" (SIR) is the quantity of Frequency Therapeutics shares currently shorted divided by the average quantity of Frequency Therapeutics shares traded daily (recently around 537557.22713864). Frequency Therapeutics's SIR currently stands at 10.17. In other words for every 100,000 Frequency Therapeutics shares traded daily on the market, roughly 10170 shares are currently held short.

However Frequency Therapeutics's short interest can also be evaluated against the total number of Frequency Therapeutics shares, or, against the total number of tradable Frequency Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Frequency Therapeutics's short interest could be expressed as 0.16% of the outstanding shares (for every 100,000 Frequency Therapeutics shares in existence, roughly 160 shares are currently held short) or 0.18% of the tradable shares (for every 100,000 tradable Frequency Therapeutics shares, roughly 180 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Frequency Therapeutics.

Find out more about how you can short Frequency Therapeutics stock.

Frequency Therapeutics share dividends

We're not expecting Frequency Therapeutics to pay a dividend over the next 12 months.

Frequency Therapeutics overview

Frequency Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc.

Stocks similar to Frequency Therapeutics

Frequently asked questions

What percentage of Frequency Therapeutics is owned by insiders or institutions?
Currently 12.329% of Frequency Therapeutics shares are held by insiders and 60.161% by institutions.
How many people work for Frequency Therapeutics?
Latest data suggests 83 work at Frequency Therapeutics.
When does the fiscal year end for Frequency Therapeutics?
Frequency Therapeutics's fiscal year ends in December.
Where is Frequency Therapeutics based?
Frequency Therapeutics's address is: 75 Hayden Avenue, Lexington, MA, United States, 02421
What is Frequency Therapeutics's ISIN number?
Frequency Therapeutics's international securities identification number is: US35803L1089
What is Frequency Therapeutics's CUSIP number?
Frequency Therapeutics's Committee on Uniform Securities Identification Procedures number is: 35803L108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site